Loss of heterozygosity induced by a chromosomal double-strand break

Por Moynahan, Mary Ellen, Jasin, Maria
Publicado em 1997

Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

Por Moynahan, Mary Ellen, Jasin, Maria
Publicado em 2010

Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations

Por Richardson, Christine, Moynahan, Mary Ellen, Jasin, Maria
Publicado em 1998

When genome maintenance goes (badly) awry

Por Kass, Elizabeth M., Moynahan, Mary Ellen, Jasin, Maria
Publicado no Mol Cell (2016)

PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

Por Ito, Shuhei, Murphy, Conleth G., Doubrovina, Ekaterina, Jasin, Maria, Moynahan, Mary Ellen
Publicado no PLoS One (2016)

Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation

Por Kass, Elizabeth M., Lim, Pei Xin, Helgadottir, Hildur R., Moynahan, Mary Ellen, Jasin, Maria
Publicado no Nat Commun (2016)

BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks

Por Westermark, Ulrica K., Reyngold, Marsha, Olshen, Adam B., Baer, Richard, Jasin, Maria, Moynahan, Mary Ellen
Publicado em 2003

Homology-directed Fanconi anemia pathway crosslink repair is dependent on DNA replication

Por Nakanishi, Koji, Cavallo, Francesca, Perrouault, Loïc, Giovannangeli, Carine, Moynahan, Mary Ellen, Barchi, Marco, Brunet, Erika, Jasin, Maria
Publicado em 2011

Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase

Por Kass, Elizabeth M., Helgadottir, Hildur R., Chen, Chun-Chin, Barbera, Maria, Wang, Raymond, Westermark, Ulrica K., Ludwig, Thomas, Moynahan, Mary Ellen, Jasin, Maria
Publicado em 2013

Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhi...

Por Cavallo, Francesca, Graziani, Grazia, Antinozzi, Cristina, Feldman, Darren R., Houldsworth, Jane, Bosl, George J., Chaganti, Raju S. K., Moynahan, Mary Ellen, Jasin, Maria, Barchi, Marco
Publicado em 2012

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR(+), HER2(−) advanced breast cancer: results from BOLERO-2

Por Moynahan, Mary Ellen, Chen, David, He, Wei, Sung, Patricia, Samoila, Aliaksandra, You, Daoqi, Bhatt, Trusha, Patel, Parul, Ringeisen, Francois, Hortobagyi, Gabriel N, Baselga, Jose, Chandarlapaty, Sarat
Publicado no Br J Cancer (2017)

Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

Por Chandarlapaty, Sarat, Chen, David, He, Wei, Sung, Patricia, Samoila, Aliaksandra, You, Daoqi, Bhatt, Trusha, Patel, Parul, Voi, Maurizio, Gnant, Michael, Hortobagyi, Gabriel, Baselga, José, Moynahan, Mary Ellen
Publicado no JAMA Oncol (2016)

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-S...

Por Dickler, Maura N., Barry, William T., Cirrincione, Constance T., Ellis, Matthew J., Moynahan, Mary Ellen, Innocenti, Federico, Hurria, Arti, Rugo, Hope S., Lake, Diana E., Hahn, Olwen, Schneider, Bryan P., Tripathy, Debasish, Carey, Lisa A., Winer, Eric P., Hudis, Clifford A.
Publicado no J Clin Oncol (2016)

Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells

Por Abraham, Jacinth, Lemmers, Bénédicte, Hande, M.Prakash, Moynahan, Mary Ellen, Chahwan, Charly, Ciccia, Alberto, Essers, Jeroen, Hanada, Katsuhiro, Chahwan, Richard, Khaw, Aik Kia, McPherson, Peter, Shehabeldin, Amro, Laister, Rob, Arrowsmith, Cheryl, Kanaar, Roland, West, Stephen C., Jasin, Maria, Hakem, Razqallah
Publicado em 2003

Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis

Por Fang, Fang, Turcan, Sevin, Rimner, Andreas, Kaufman, Andrew, Giri, Dilip, Morris, Luc G. T., Shen, Ronglai, Seshan, Venkatraman, Mo, Qianxing, Heguy, Adriana, Baylin, Stephen B., Ahuja, Nita, Viale, Agnes, Massague, Joan, Norton, Larry, Vahdat, Linda T., Moynahan, Mary Ellen, Chan, Timothy A.
Publicado em 2011

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Por Gucalp, Ayca, Tolaney, Sara, Isakoff, Steven J., Ingle, James N., Liu, Minetta C., Carey, Lisa A., Blackwell, Kimberly, Rugo, Hope, Nabell, Lisle, Forero, Andres, Stearns, Vered, Doane, Ashley S., Danso, Michael, Moynahan, Mary Ellen, Momen, Lamia F., Gonzalez, Joseph M., Akhtar, Arooj, Giri, Dilip D., Patil, Sujata, Feigin, Kimberly N., Hudis, Clifford A., Traina, Tiffany A.
Publicado em 2013

A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin–Cyclophosphamide (AC) Followed by Nanoparticle Albumin–Bound Paclitaxel in Early-Stage Breast Cancer

Por McArthur, Heather L., Rugo, Hope, Nulsen, Benjamin, Hawks, Laura, Grothusen, Jill, Melisko, Michelle, Moasser, Mark, Paulson, Matthew, Traina, Tiffany, Patil, Sujata, Zhou, Qin, Steingart, Richard, Dang, Chau, Morrow, Monica, Cordeiro, Peter, Fornier, Monica, Park, John, Seidman, Andrew, Lake, Diana, Gilewski, Theresa, Theodoulou, Maria, Modi, Shanu, D’Andrea, Gabriella, Sklarin, Nancy, Robson, Mark, Moynahan, Mary Ellen, Sugarman, Steven, Sealey, Jane E., Laragh, John H., Merali, Carmen, Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Publicado no Clin Cancer Res (2011)